# Chronic Pain in a Modern Virally Suppressed HIV Cohort: Associations with Comorbidities Depression and Disability

**Authors:** Ronald J. Ellis, Robert K. Heaton, J. Hampton Atkinson, Murray Stein, Crystal Wang, Tyler R. Bell, Andrew Miller, David Grelotti, David Moore

PMC · DOI: 10.21203/rs.3.rs-6631567/v1 · Research Square · 2025-06-24

## TL;DR

People with HIV on modern treatment still experience chronic pain more often than those without HIV, which affects their daily life and mood.

## Contribution

This study identifies chronic pain as a persistent issue in virally suppressed HIV patients, linking it to depression and disability.

## Key findings

- Chronic pain was significantly more frequent in people with HIV (60%) compared to those without HIV (22%).
- Chronic pain in HIV patients was associated with higher opioid use and greater interference with daily activities.
- Chronic pain was linked to higher depression scores in HIV-positive individuals.

## Abstract

Chronic pain (CP) is common among people with HIV (PWH), yet its prevalence and associated factors in those receiving modern, virally suppressive antiretroviral therapy (ART) are not well understood. This prospective observational study compared CP frequency and associated outcomes between PWH and people without HIV (PWoH). Participants (40 PWH, 23 PWoH) completed a questionnaire assessing daily pain lasting more than three months. Additional data included pain intensity, interference with daily activities, opioid use, and depressed mood (Beck Depression Inventory-II), as well as HIV clinical markers and comorbidities. Groups were demographically similar; all PWH were virally suppressed, with a median HIV duration of 30.6 years, nadir CD4 count of 300 cells/μL, and current CD4 count of 644 cells/μL. CP was significantly more frequent in PWH (60%) than in PWoH (22%; OR = 5.4 [1.67, 17.5]; p = 0.0028). Among PWH, CP was associated with greater daily activity interference, higher opioid use (38% vs. 6%), and increased neuropathic pain symptoms. PWH with CP also had higher BDI-II scores, indicating worse mood. These findings suggest that CP remains prevalent and disabling among PWH despite effective modern-day ART, underscoring the need for targeted pain assessment and management in this population.

## Linked entities

- **Diseases:** depression (MONDO:0002050)

## Full-text entities

- **Genes:** CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}
- **Diseases:** CP (MESH:D059350), pain (MESH:D010146), HIV (MESH:D015658), Depression (MESH:D003866), neuropathic pain (MESH:D009437)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12270198/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12270198/full.md

## References

60 references — full list in the complete paper: https://tomesphere.com/paper/PMC12270198/full.md

---
Source: https://tomesphere.com/paper/PMC12270198